MedTrace Logo

Eswatini Ring Study: Increasing PrEP Options for Women

NCT05889533 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 904

Last updated 2025-03-18

No results posted yet for this study

Summary

The study will deliver PrEP choice between oral PrEP and the PrEP ring for women in PEPFAR/USAID public health service delivery sites, building on the existing PrEP service delivery models at each site and in accordance with national guidelines for PrEP service delivery in Eswatini. The overall goal of the study is to characterize and assess the feasibility, acceptability, uptake, patterns of use, and clinical outcomes of an enhanced service delivery package providing fully informed choice of oral PrEP and the PrEP ring among women, especially adolescent girls and young women, in Eswatini.

Conditions

  • HIV Prevention

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • FHI 360

    lead OTHER

Principal Investigators

  • Anita Hettema, MPH · FHI 360

  • Sindy Matse, MPH · Ministry of Health

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-09
Primary Completion
2025-01-27
Completion
2025-01-27

Countries

  • Eswatini

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05889533 on ClinicalTrials.gov